Skip to content
Biodatica
Start free

Investigator

Rahul Pal

MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NCI, NIBIB

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$607k

Summed across those awards.

First award
Aug 1, 2025

Latest Jun 8, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Fluorescence lifetime imaging for quantitative assessment of in vivo PD-L1 target engagement.

    $437k

    Jun 8, 2026NCIMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11435871 (opens the source filing in a new tab)

  2. K01

    Developing a library of near-infrared fluorophores for multiplexed in vivo fluorescence lifetime imaging of disease biomarkers.

    $170k

    Aug 1, 2025NIBIBMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11212715 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources